Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receptor tyrosine-protein kinase erbB-3(ERBB3)His Tag | Login | Receptor tyrosine-protein kinase erbB-3(ERBB3)His Tag | ||||||||||||||||
|
||||||||||||||||||
T cell receptor delta variable 1(TRDV1) | Login | T cell receptor delta variable 1(TRDV1) | ||||||||||||||||
|
||||||||||||||||||
Thioredoxin 1(trxA) (Escherichia coli) | Login | Thioredoxin 1(trxA) (Escherichia coli) | ||||||||||||||||
|
||||||||||||||||||
Thioredoxin domain-containing protein 5(TXNDC5) | Login | Thioredoxin domain-containing protein 5(TXNDC5) | ||||||||||||||||
|
||||||||||||||||||
Thioredoxin reductase 1, cytoplasmic(TXNRD1)(E.coli production) | Login | Thioredoxin reductase 1, cytoplasmic(TXNRD1)(E.coli production) | ||||||||||||||||
|
||||||||||||||||||
Tumor necrosis factor alpha-induced protein 3 (TNFAIP3) | Login | Tumor necrosis factor alpha-induced protein 3 (TNFAIP3) | ||||||||||||||||
|
||||||||||||||||||
Tumor necrosis factor ligand superfamily member 11(TNFSF11) | Login | Tumor necrosis factor ligand superfamily member 11(TNFSF11) | ||||||||||||||||
|
||||||||||||||||||
Tumor necrosis factor receptor superfamily member 19L(Relt) | Login | Tumor necrosis factor receptor superfamily member 19L(Relt) | ||||||||||||||||
|
||||||||||||||||||
Tumor necrosis factor receptor superfamily member 6(FAS) (Gln26-Asn173) | Login | Tumor necrosis factor receptor superfamily member 6(FAS) (Gln26-Asn173) | ||||||||||||||||
|
||||||||||||||||||
Epidermal growth factor receptor(EGFR) | Login | Epidermal growth factor receptor(EGFR) | ||||||||||||||||
|
||||||||||||||||||
Cyclin-dependent kinase 4 inhibitor B(CDKN2B) | Login | Cyclin-dependent kinase 4 inhibitor B(CDKN2B) | ||||||||||||||||
|
||||||||||||||||||
c-JUN Protein / Transcription factor AP-1(JUN) | Login | c-JUN Protein / Transcription factor AP-1(JUN) | ||||||||||||||||
|
||||||||||||||||||
Fibroblast growth factor 21(FGF21)(29-210) | Login | Fibroblast growth factor 21(FGF21)(29-210) | ||||||||||||||||
|
||||||||||||||||||
Fibroblast growth factor 23(FGF23) | Login | Fibroblast growth factor 23(FGF23) | ||||||||||||||||
|
||||||||||||||||||
G1/S-specific cyclin-D1(CCND1) | Login | G1/S-specific cyclin-D1(CCND1) | ||||||||||||||||
|
||||||||||||||||||
Mucin-4(MUC4)(2078-2117) | Login | Mucin-4(MUC4)(2078-2117) | ||||||||||||||||
|
||||||||||||||||||
RAC-gamma serine/threonine-protein kinase(AKT3) | Login | RAC-gamma serine/threonine-protein kinase(AKT3) | ||||||||||||||||
|
||||||||||||||||||
Runt-related transcription factor 1 (RUNX1) | Login | Runt-related transcription factor 1 (RUNX1) | ||||||||||||||||
|
||||||||||||||||||
Anti-IL3RA/CD123(Homo sapiens) (Nofetumomab ) Monoclonal Antibody | Login | Anti-IL3RA/CD123(Homo sapiens) (Nofetumomab ) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
Anti-IL3RA/CD123(Homo sapiens) (Nofetumomab ) Monoclonal Antibody | Login | Anti-IL3RA/CD123(Homo sapiens) (Nofetumomab ) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
Anti-MUC16/CA125(Homo sapiens) (Oregovomab) Monoclonal Antibody | Login | Anti-MUC16/CA125(Homo sapiens) (Oregovomab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
Anti-MUC16/CA125(Homo sapiens) (Oregovomab) Monoclonal Antibody | Login | Anti-MUC16/CA125(Homo sapiens) (Oregovomab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
Anti-CSPG4/HMW-MAA/CD3E/ERBB2(Homo sapiens),toxin(Clostridium perfringens) (Tecnemab ) Monoclonal Antibody | Login | Anti-CSPG4/HMW-MAA/CD3E/ERBB2(Homo sapiens),toxin(Clostridium perfringens) (Tecnemab ) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
Anti-CSPG4/HMW-MAA/CD3E/ERBB2(Homo sapiens),toxin(Clostridium perfringens) (Tecnemab ) Monoclonal Antibody | Login | Anti-CSPG4/HMW-MAA/CD3E/ERBB2(Homo sapiens),toxin(Clostridium perfringens) (Tecnemab ) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
Anti-MS4A1/CD20(Homo sapiens) (Tositumomab) Monoclonal Antibody | Login | Anti-MS4A1/CD20(Homo sapiens) (Tositumomab) Monoclonal Antibody | ||||||||||||||||
|